Mersana Therapeutics (NASDAQ:MRSN) will release its quarterly earnings report on Wednesday, 2025-08-13. Here's a brief overview for investors ahead of the announcement.
Analysts anticipate Mersana Therapeutics to report an earnings per share (EPS) of $-4.05.
Anticipation surrounds Mersana Therapeutics's announcement, with investors hoping to hear about both surpassing estimates and receiving positive guidance for the next quarter.
New investors should understand that while earnings performance is important, market reactions are often driven by guidance.
Earnings History Snapshot
During the last quarter, the company reported an EPS missed by $0.00, leading to a 8.14% increase in the share price on the subsequent day.
Here's a look at Mersana Therapeutics's past performance and the resulting price change:
| Quarter | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| EPS Estimate | -0.19 | -0.15 | -0.17 | -0.17 |
| EPS Actual | -0.19 | -0.11 | -0.09 | -0.20 |
| Price Change % | 8.0% | 6.0% | -4.0% | -9.0% |
Stock Performance
Shares of Mersana Therapeutics were trading at $5.97 as of August 11. Over the last 52-week period, shares are down 80.36%. Given that these returns are generally negative, long-term shareholders are likely upset going into this earnings release.
To track all earnings releases for Mersana Therapeutics visit their earnings calendar on our site.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
